+
Connext Tour

Dr Ingo Eitel explains why LAAO can be an option in ESKD patients

Dr Ingo Eitel explains why left atrial appendage occlusion can be an option in end stage kidney disease (ESKD) patients 

Related Videos

LAAO Summit - Decoding DRT patient factors

LAAO Summit - Imaging debate: Mini TEE

LAAO Summit - LAAO with risk of leak

LAAO Summit - The right antithrombotic regimen

LAAO Summit 2023: Stroke severity

LAAO Summit - Pre-procedural imaging

LAAO Summit - Sealing the appendage

LAAO Summit - Debate: Factor XI inhibitors

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

Monitoring for AF prior to PFO closure

The Amulet IDE Trial

Amplatzer™ Amulet™ LAA Occluder

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - LAA anatomy focusing

LAAO Summit - Mastering leaks

LAAO Summit - Device placement and DRT

LAAO Summit - Imaging debate: ICE

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline